<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05611151</url>
  </required_header>
  <id_info>
    <org_study_id>WV-2022-01</org_study_id>
    <nct_id>NCT05611151</nct_id>
  </id_info>
  <brief_title>Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy</brief_title>
  <acronym>COLOWISE</acronym>
  <official_title>Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy: Prospective, Randomized Clinical Performance Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NEC Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Meditrial Europe Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NEC Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, randomized study to evaluate the clinical performance of&#xD;
      a novel CADe device, WISE VISION® Endoscopy System, in patients undergoing high-definition&#xD;
      white light (HDWL) colonoscopy for screening or surveillance of colorectal Cancer (CRC).&#xD;
&#xD;
      Eligible subjects who meet the study inclusion/exclusion criteria will be randomized in a 1:1&#xD;
      ratio to undergo colonoscopy :&#xD;
&#xD;
        -  Experimental: CADe colonoscopy procedure with WISE VISION® Endoscopy (CADe Group)&#xD;
&#xD;
        -  Control: Standard Colonoscopy without CADe (Standard Colonoscopy Group)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to evaluate whether NEC WISE VISION® Endoscopy enhances the ability to detect&#xD;
      mucosal lesions when compared with the current standard-of-care procedure (high-definition&#xD;
      white light [HDWL] colonoscopy). The CADe device, Wise VISION® Endoscopy, contains an&#xD;
      artificial intelligence/machine learning (AI/ML) advanced algorithm to aid the endoscopists&#xD;
      in detection of colonic lesions.&#xD;
&#xD;
      This study plans to enrol 700 subjects aged ≥ 45 years and &lt; 75 years, who are scheduled for&#xD;
      screening or surveillance colonoscopy.&#xD;
&#xD;
      After review of the inclusion and exclusion criteria, eligible subjects will be randomized in&#xD;
      a 1:1 ratio to receive either computer-aided colonoscopy (CADe Group) or standard colonoscopy&#xD;
      without CADe (Standard Colonoscopy Group).&#xD;
&#xD;
      All adenomas, that are identified during the colonoscopies, will be removed and biopsied as&#xD;
      per standard clinical practice to assess adenoma miss rate, polyp miss rate, adenomas per&#xD;
      colonoscopy and other endpoints.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2023</start_date>
  <completion_date type="Anticipated">January 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel trial design</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenomas per Colonoscopy (APC)</measure>
    <time_frame>during the procedure/surgery</time_frame>
    <description>Total number of histologically confirmed adenomas resected divided by the total number of colonoscopies.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Adenoma Colon</condition>
  <condition>Polyp of Colon</condition>
  <arm_group>
    <arm_group_label>CADe Colonoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CADe Colonoscopy: Patient undergoes WISE VISION® Endoscopy CADe colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HDWL Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HDWL Colonoscopy: Patient undergoes HDWL colonoscopy without CADe</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Computer Aided Detection (CADe)</intervention_name>
    <description>Computer-aided detection (CADe) devices are used in conjunction with colonoscopy to aid in the detection of lesions in the gastrointestinal tract.</description>
    <arm_group_label>CADe Colonoscopy</arm_group_label>
    <arm_group_label>HDWL Colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is presenting to the endoscopy unit for colon cancer screening or surveillance&#xD;
             colonoscopy.&#xD;
&#xD;
          -  Signed Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications to colonoscopy&#xD;
&#xD;
          2. Colonoscopy within the previous three (3) years&#xD;
&#xD;
          3. High-risk indications for colonoscopy&#xD;
&#xD;
          4. Antithrombotic therapy that cannot be stopped, precluding polyp resection&#xD;
&#xD;
          5. Inflammatory bowel disease&#xD;
&#xD;
          6. Referred for endoscopic mucosal resection (EMR)&#xD;
&#xD;
          7. Familial adenomatous polyposis syndrome or Serrated Polyposis Syndrome&#xD;
&#xD;
          8. Pregnant or planning a pregnancy during the study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hitoshi Ikeda</last_name>
    <role>Study Director</role>
    <affiliation>NEC Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica Tocchi, MD, PhD</last_name>
    <phone>+1 646 933 1025</phone>
    <email>m.tocchi@meditrial.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>GastroZentrum Lippe</name>
      <address>
        <city>Bad Salzuflen</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Helmut Neumann, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Humanitas Mater Domini</name>
      <address>
        <city>Castellanza</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Benedetto Mangiavillano, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Alessandro Repici, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Portsmouth Hospitals University NHS Trust, Cosham</name>
      <address>
        <city>Portsmouth</city>
        <zip>PO6 3LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Pradeep Bhandari, Prof.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.nec.com/en/global/wisevision/index.html</url>
    <description>NEC WISE VISION® Endoscopy</description>
  </link>
  <link>
    <url>http://meditrial.com</url>
    <description>Meditrial Clinical Research Organization</description>
  </link>
  <reference>
    <citation>Yamada M, Saito Y, Imaoka H, Saiko M, Yamada S, Kondo H, Takamaru H, Sakamoto T, Sese J, Kuchiba A, Shibata T, Hamamoto R. Development of a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy. Sci Rep. 2019 Oct 8;9(1):14465. doi: 10.1038/s41598-019-50567-5.</citation>
    <PMID>31594962</PMID>
  </reference>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 1, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>March 25, 2023</last_update_submitted>
  <last_update_submitted_qc>March 25, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>Artificial Intelligence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

